NAUGHTON GAIL K has a total of 13 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are NEUROTROPHINCELL PTY LTD, OSIRIS THERAPEUTICS INC and THEREGEN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Organic fine chemistry | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Object sterilising | |
#5 | Specific use of cosmetics | |
#6 | Peptides | |
#7 | Fermentation | |
#8 | Special foods | |
#9 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Naughton Gail K | 13 |
#2 | Baumgartner Mark | 4 |
#3 | Ziegler Frank | 4 |
#4 | Nickey Kyle | 4 |
#5 | Zeltinger Joan | 3 |
#6 | Pinney R Emmett | 2 |
#7 | Mansbridge Jonathan N | 2 |
#8 | Horwitz David L | 2 |
#9 | Pinney Emmett | 2 |
#10 | Landeen Lee K | 2 |
Publication | Filing date | Title |
---|---|---|
US2010210530A1 | Soluble composition for promoting hair growth produced by hypoxic culture of fibroblasts cells | |
US2010196963A1 | Low oxygen tension and BFGF generates a multipotent stem cell from a fibroblast in vitro | |
US2010158975A1 | Repair and/or regeneration of cells with a composition produced by culturing fibroblast cells under hypoxic conditions | |
WO2010005594A1 | Compositions and methods of producing ursodeoxycholic acid | |
US2006134074A1 | Compositions and methods for promoting hair growth |